Associated Papers
A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders.
Katagiri T et al.
Nature Communications, 2023
37231012 (PubMed )
Supplement: 41467_2023_38746_MOESM1_ESM.pdf
Pathogenic mutation of ALK2 inhibits induced pluripotent stem cell reprogramming and maintenance: mechanisms of reprogramming and strategy for drug identification.
Hamasaki M et al.
Stem Cells (dayton, Ohio), 2012
Select a paper to view details